Literature DB >> 2869278

Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin.

S Bonfils, P Ruszniewski, V Costil, H Laucournet, J Vatier, E Rene, M Mignon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2869278     DOI： 10.1016/s0140-6736(86)90905-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014.

Authors:  J M Kuhn; C Basin; M Mollard; B de Rougé; C Baudoin; R Obach; G Tolis
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 2.  Medical treatment of gastrinomas.

Authors:  Christoph J Auernhammer; Burkhard Göke
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

3.  Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.

Authors:  H S Füessl; W G Zoller; M M Kochen; J R Bogner; B Heinrich; A Matuschke; F D Goebel
Journal:  Klin Wochenschr       Date:  1989-04-17

4.  Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers.

Authors:  J M Kuhn; A Legrand; J M Ruiz; R Obach; J De Ronzan; F Thomas
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

5.  Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.

Authors:  P Ruszniewski; F Girard; R Benamouzig; M Mignon; S Bonfils
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

Review 6.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 7.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.